Literature DB >> 18480417

Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.

Vincent H Gattone1, Tibério M Siqueira, Charles R Powell, Chad M Trambaugh, James E Lingeman, Arieh L Shalhav.   

Abstract

The kidney has both afferent (sensory) and efferent (sympathetic) nerves that can influence renal function. Renal innervation has been shown to play a role in the pathogenesis of many forms of hypertension. Hypertension and flank pain are common clinical manifestations of autosomal dominant (AD) polycystic kidney disease (PKD). We hypothesize that renal innervation contributes to the hypertension and progression of cystic change in rodent PKD. In the present study, the contribution of renal innervation to hypertension and progression of renal histopathology and dysfunction was assessed in male Han:SPRD-Cy/+ rats with ADPKD. At 4 weeks of age, male offspring from crosses of heterozygotes (Cy/+) were randomized into either 1) bilateral surgical renal denervation, 2) surgical sham denervation control, or 3) nonoperated control groups. A midline laparotomy was performed to allow the renal denervation (i.e., physical stripping of the nerves and painting the artery with phenol/alcohol). Blood pressure (tail cuff method), renal function (BUN) and histology were assessed at 8 weeks of age. Bilateral renal denervation reduced the cystic kidney size, cyst volume density, systolic blood pressure, and improved renal function (BUN) as compared with nonoperated controls. Operated control cystic rats had kidney weights, cyst volume densities, systolic blood pressures, and plasma BUN levels that were intermediate between those in the denervated animals and the nonoperated controls. The denervated group had a reduced systolic blood pressure compared with the operated control animals, indicating that the renal innervations was a major contributor to the hypertension in this model of ADPKD. Renal denervation was efficacious in reducing some pathology, including hypertension, renal enlargement, and cystic pathology. However, sham operation also affected the cystic disease but to a lesser extent. We hypothesize that the amelioration of hypertension in Cy/+ rats was due to the effects of renal denervation on the renin angiotensin system.

Entities:  

Mesh:

Year:  2008        PMID: 18480417     DOI: 10.3181/0802-RM-54

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  12 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 2.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

Review 3.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

4.  Contributions of afferent and sympathetic renal nerves to cystogenesis and arterial pressure regulation in a preclinical model of autosomal recessive polycystic kidney disease.

Authors:  Madeline M Gauthier; Melissa R Dennis; Mark N Morales; Heddwen L Brooks; Christopher T Banek
Journal:  Am J Physiol Renal Physiol       Date:  2022-04-25

Review 5.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

Review 6.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

7.  The mechanosensory role of primary cilia in vascular hypertension.

Authors:  Surya M Nauli; Xingjian Jin; Beerend P Hierck
Journal:  Int J Vasc Med       Date:  2011-06-16

8.  Effect of percutaneous renal denervation on blood pressure level and sympathetic activity in a patient with polycystic kidney disease.

Authors:  Aleksander Prejbisz; Jacek Kądziela; Jacek Lewandowski; Elżbieta Florczak; Ewa Zylińska; Mariusz Kłopotowski; Adam Witkowski; Andrzej Januszewicz
Journal:  Clin Res Cardiol       Date:  2013-12-10       Impact factor: 5.460

Review 9.  Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.

Authors:  Jasdeep Kaur; Benjamin E Young; Paul J Fadel
Journal:  Int J Mol Sci       Date:  2017-08-02       Impact factor: 5.923

10.  Renal denervation does not affect hypertension or the renin-angiotensin system in a rodent model of juvenile-onset polycystic kidney disease: clinical implications.

Authors:  Sheran Li; Cara M Hildreth; Ahmed A Rahman; Sean A Barton; Benjamin F Wyse; Chai K Lim; Paul M Pilowsky; Jacqueline K Phillips
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.